Recently, in AF N-terminal pro-B-type natriuretic peptide (NT-proBNP) and high-sensitivity cardiac troponin (cTn-hs) have been shown to be strong and independent predictors of thromboembolism and when combined with clinical data, improve stroke risk assessment [3, 4]. This evidence concerns the gene NPPB and stroke disorder.